BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27898364)

  • 1. Liquid chromatography-tandem mass spectrometry assay for the quantification of niraparib and its metabolite M1 in human plasma and urine.
    van Andel L; Zhang Z; Lu S; Kansra V; Agarwal S; Hughes L; Tibben MM; Gebretensae A; Rosing H; Schellens JHM; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():14-21. PubMed ID: 27898364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an integrated LC-MS/MS assay for therapeutic drug monitoring of five PARP-inhibitors.
    Bruin MAC; de Vries N; Lucas L; Rosing H; Huitema ADR; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Feb; 1138():121925. PubMed ID: 31915109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mass balance study and metabolite profiling of
    van Andel L; Zhang Z; Lu S; Kansra V; Agarwal S; Hughes L; Tibben MM; Gebretensae A; Lucas L; Hillebrand MJX; Rosing H; Schellens JHM; Beijnen JH
    Invest New Drugs; 2017 Dec; 35(6):751-765. PubMed ID: 28303528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-performance liquid chromatography-tandem mass spectrometry method for simultaneous determination of imigliptin, its five metabolites and alogliptin in human plasma and urine and its application to a multiple-dose pharmacokinetic study.
    Liu Y; Song L; Yao X; Wu Y; Liu H; Zhao Q; Jiang J; Shi C; Ma X; Zhou H; Liu D; Hu P
    Biomed Chromatogr; 2018 Nov; 32(11):e4324. PubMed ID: 29952007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput assay for quantification of the plasma concentrations of thiopental using automated solid phase extraction (SPE) directly coupled to LC-MS/MS instrumentation.
    Moosavi SM; Shekar K; Fraser J; Smith MT; Ghassabian S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():80-87. PubMed ID: 27802918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validated LC-MS/MS method for determination of neuro-pharmacokinetic behavior of niraparib in brain tumor patients.
    Knight W; Margaryan T; Sanai N; Tovmasyan A
    J Pharm Biomed Anal; 2024 Aug; 245():116150. PubMed ID: 38657366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of blonanserin and its metabolite in human plasma and urine by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
    Wen YG; Ni XJ; Zhang M; Liu X; Shang DW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():46-52. PubMed ID: 22818206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a
    van Andel L; Rosing H; Zhang Z; Hughes L; Kansra V; Sanghvi M; Tibben MM; Gebretensae A; Schellens JHM; Beijnen JH
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):39-46. PubMed ID: 29043410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of high-performance liquid chromatography-tandem mass spectrometry assays quantifying omacetaxine mepesuccinate and its 4'‑des-methyl and cephalotaxine metabolites in human plasma and urine.
    Nijenhuis CM; Lucas L; Rosing H; Schellens JH; Beijnen JH; Gorman SH; Burke SM; Campbell DA; Chapple MW; Yousey TH; Mulvana DE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():152-9. PubMed ID: 26319804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive quantification of diphemanil methyl sulphate in human plasma by liquid chromatography-tandem mass spectrometry.
    Do B; Goulay-Dufaÿ S; Le Hoang MD; Adoui N; Graffard H; Guyon F; Pradeau D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):104-8. PubMed ID: 16962397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of vosaroxin and its metabolites N-desmethylvosaroxin and O-desmethylvosaroxin in human plasma and urine using high-performance liquid chromatography-tandem mass spectrometry.
    Nijenhuis CM; Lucas L; Rosing H; Jamieson G; Fox JA; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():1-10. PubMed ID: 27236532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an LC-MS/MS method with a broad linear dynamic range for the quantification of tivozanib in human and mouse plasma, mouse tissue homogenates, and culture medium.
    Bruin MAC; Rosing H; Lucas L; Wang J; Huitema ADR; Schinkel AH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1125():121723. PubMed ID: 31352204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β‑decitabine in human plasma, whole blood and urine.
    Roosendaal J; Wang K; Rosing H; Lucas L; Gebretensae A; Oganesian A; Schellens JHM; Beijnen JH; Lin ZJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():132-141. PubMed ID: 30754019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A liquid chromatography-tandem mass spectrometric assay for the antihypertensive agent azelnidipine in human plasma with application to clinical pharmacokinetics studies.
    Gao Y; Li B; Zhu B; Liu D; Zhao H; Fang Z; Wang H; Lou H
    Biomed Chromatogr; 2015 Jul; 29(7):970-4. PubMed ID: 25472837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of LBPT in human plasma by high performance liquid chromatography-tandem mass spectrometry.
    Liu M; Wang H; Liu H; Peng A; Yang F; Wang W; Zhu L; Huang H; Jiang J; Hu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():238-43. PubMed ID: 25049213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of gypenoside LVI, gypenoside XLVI, 2α-OH-protopanaxadiol and their two metabolites in rat plasma by LC-MS/MS and its application to pharmacokinetic studies.
    Zhang L; Lin Y; Guan H; Hu L; Pan G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Nov; 1005():9-16. PubMed ID: 26454343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma.
    Xue YJ; Akinsanya JB; Liu J; Unger SE
    Rapid Commun Mass Spectrom; 2006; 20(18):2660-8. PubMed ID: 16912986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a sensitive LC-MS/MS assay for the simultaneous quantification of allitinib and its two metabolites in human plasma.
    Lin L; Gao Z; Chen X; Zhong D
    J Pharm Biomed Anal; 2013 Dec; 86():49-55. PubMed ID: 23973791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
    Figurski MJ; Korecka M; Fields L; Waligórska T; Shaw LM
    Ther Drug Monit; 2009 Dec; 31(6):717-26. PubMed ID: 19809389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.